Featured News
701Wire StoriesArcturus Announces Approval of a Clinical Trial Application to Advance ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting the SARS-CoV-2 Delta Variant and Other Variants of Concern
The Phase 1/2/3 trial to be funded and sponsored by Arcturus’ manufacturing partner Vinbiocare ARCT-154 to be developed in parallel with ARCT-021,...
- 717Wire Stories
LianBio Appoints Pascal Qian as General Manager of China
SHANGHAI & PRINCETON, N.J.–(BUSINESS WIRE)–LianBio, a biotechnology company dedicated to bringing paradigm-shifting medicines to patients in China and other major Asian markets,...
- 830Wire Stories
SaNOtize inks agreement with Indian biotech Glenmark to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets
Nitric oxide (NO) has antimicrobial properties with direct proven effect on SARS-CoV-2 Nitric Oxide Nasal Spray (NONS) has been tested in healthy...
- 693Wire Stories
Coca-Cola Europacific Partners Indonesia Taps 8×8 CPaaS to Enhance Mobile Experience for Business-to-Business (B2B) Customers in Indonesia
Deploys 8×8 SMS API to Ensure Mobile App Security with One-Time Password (OTP) Multi-Factor Authentication CAMPBELL, Calif.–(BUSINESS WIRE)–8×8, Inc. (NYSE: EGHT), a...
- 596Wire Stories
Fabrinet to Announce Fourth Quarter and Fiscal-Year 2021 Financial Results on August 16, 2021
BANGKOK–(BUSINESS WIRE)–#EarningsDate–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment...
- 591Wire Stories
CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Accepted by China’s National Medical Products Administration
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc., a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development and commercialization...
- 651Wire Stories
Esri Signs Goodwill Protocol with Atlas University
Turkish Institution Will Offer GIS Training, Provide Space for Research and Development REDLANDS, Calif.–(BUSINESS WIRE)–Esri, the global leader in location intelligence, today...
- 584Wire Stories
IASO Biotherapeutics’ World’s First Fully Human CD19/CD22 Dual-Targeted CAR-T Drug Receives Two IND Clearances, Enters Clinical Trials
NMPA’s Clearance of CT120 Marks Major Milestone in Treatment for B-Cell Malignancies PLEASANTON, Calif. & NANJING, China & SHANGHAI–(BUSINESS WIRE)–#Biopharmaceutical—IASO Biotherapeutics (IASO...
- 766Wire Stories
News Corp to Acquire OPIS
Leading Data and Analytics Provider for Energy and Commodities Markets Will Provide New Pillars of Growth for Dow Jones Growing, High Margin,...
- 795Wire Stories
Arcturus Therapeutics Collaborates with Vingroup to Establish Manufacturing Facility in Vietnam for Arcturus’ Investigational mRNA Vaccines for COVID-19
Arcturus will receive $40 million upfront payment and potential royalties based on vaccines produced SAN DIEGO–(BUSINESS WIRE)–$ARCT #ClinicalTrial–Arcturus Therapeutics Holdings Inc. (the...
- 921Wire Stories
Overland Pharmaceuticals Appoints Roger Luo, Ph.D. as Chief Development Officer
Experienced pharmaceutical research and development strategist brings deep expertise in advancing innovative cancer medicines SHANGHAI & BOSTON–(BUSINESS WIRE)–Overland Pharmaceuticals (“Overland”), a premier...
